Company TOT BIOPHARM International Company Limited
Equities
1875
HK0000545266
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.68 HKD | +6.33% | +10.53% | -14.72% |
Mar. 15 | TOT BIOPHARM International Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | TOT Biopharm's Loss Narrows in January-September Period | MT |
Business Summary
Number of employees: 552
Sales per Business
HKD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Anti-tumor Drugs and Self-developed Biological Drugs
100.0
%
| 92 | 100.0 % | 514 | 100.0 % | +458.99% |
Sales per region
HKD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
China
100.0
%
| 85 | 92.3 % | 514 | 100.0 % | +505.67% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Jun Liu
CEO | Chief Executive Officer | 56 | 16-10-16 |
Ben Xiao
DFI | Director of Finance/CFO | 42 | 21-12-31 |
Ming Liu
CTO | Chief Tech/Sci/R&D Officer | 63 | 17-08-27 |
Director/Board Member | 65 | 10-07-04 | |
Shan Feng
LAW | General Counsel | 45 | 14-11-30 |
Yi Fan Chen
SEC | Corporate Secretary | 44 | 20-04-30 |
Wing Yat Lui
SEC | Corporate Secretary | 35 | 19-04-15 |
Chi-Yuen Wu
PRN | Corporate Officer/Principal | 52 | 15-12-31 |
Chun-Ming Lin
SAM | Sales & Marketing | 50 | 15-12-31 |
Xiaobao Chen
PRN | Corporate Officer/Principal | 42 | 16-06-19 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 65 | 10-07-04 | |
Hong Jen Chang
BRD | Director/Board Member | 68 | 19-03-11 |
Shan Fu
CHM | Chairman | 56 | 16-01-18 |
Jun Liu
CEO | Chief Executive Officer | 56 | 16-10-16 |
Lan Hu
BRD | Director/Board Member | 53 | 19-03-11 |
Wei Dong Liu
BRD | Director/Board Member | 56 | 23-08-11 |
De Qian Wang
BRD | Director/Board Member | 73 | 22-03-11 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 772,787,887 | 448,300,187 ( 58.01 %) | 0 | 58.01 % |
Company contact information
TOT BIOPHARM International Co. Ltd.
No.120 Changyang Street Suzhou Industrial Park
, Suzhou
+
http://www.totbiopharm.comSector
Sales per region
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-14.72% | 156M | |
-2.31% | 103B | |
+0.56% | 95.71B | |
+1.69% | 22.02B | |
-17.37% | 20.9B | |
-9.30% | 17.85B | |
-41.01% | 16.21B | |
-14.85% | 15.52B | |
+3.21% | 13.86B | |
+33.54% | 12.04B |
- Stock Market
- Equities
- 1875 Stock
- Company TOT BIOPHARM International Company Limited